A multifunctional Fbxo2-targeted reporter in mice and stem cells was developed and characterized as a resource for inner ear studies, along with a toolbox of plasmids to facilitate the use of this technique for other users.
INTRODUCTION
The sensory organs of the inner ear contain highly specialized mechanosensory epithelia, essential for hearing and balance. The five vestibular organs and the auditory organ, the organ of Corti, originate from the otic vesicle during embryonic development and are comprised of various types of sensory hair cells and supporting cells. Auditory and vestibular hair cells are innervated respectively by spiral ganglion or vestibular ganglion neurons, which also originate in the otic vesicle. The inner ear offers an excellent developmental system to study mechanisms of lineage specification, cell fate determination, patterning, and organogenesis (Wu and Kelley, 2012) . The mouse has been a highly productive model system for inner ear studies due to advances in mouse genetics and the relative similarity of the mouse inner ear to that of humans and other mammals. Studying the murine otic lineage, however, has been challenging because very few genes are expressed exclusively in the inner ear. Most genes that have been found to be important for inner ear development play important roles in development of other organs as well (Dahl et al., 1997; Tadjuidje and Hegde, 2013; Torban and Goodyer, 2009) . Also, some genes that have been used as favored markers or exploited as transgenic tools for the developing inner ear are expressed transiently in the otocyst, which limits their use (Chatterjee et al., 2010; Wu and Kelley, 2012) .
Considerable progress has been made in ES cell models of otic development, where stem cells can be coaxed into the otic sensory lineage through manipulation of signaling to eventually produce otic sensory cell types (DeJonge et al., 2016; Ealy et al., 2016; Koehler et al., 2013; Koehler et al., 2017; Li et al., 2003; Oshima et al., 2010) . However, stem cell differentiation is inherently heterogeneous and, without highly specific and persistent otic lineage markers, it is currently necessary to assay for multiple markers at different time points in order to infer the identity of potential otic cells (Ealy et al., 2016; Koehler et al., 2013; Oshima et al., 2010; Schaefer et al., 2018) . This limitation is particularly the case for identification of otic progenitors and supporting cells, which lack the more distinguishing cytological features and expression profiles of hair cells. A second major challenge for the field is that there are limited mouse lines available for driving expression of Cre recombinase specifically in the inner ear (Cox et al., 2012) .
We recently isolated and characterized mouse otic sensory lineage-specific genes and identified Fbxo2 as the most differentially expressed otic gene at embryonic day 10.5 (E10.5) (Hartman et al., 2015) .
Fbxo2 encodes the ubiquitin ligase subunit F-box 2 (Fbx2), which we found to be strongly expressed in the developing inner ear starting at E10.5. Consistent with our previous study, Fbxo2 mRNA is specifically detectable in the mouse inner ear at E14.5, with little or no signal in other tissues of the embryo (Fig. 1A , Eurexpress database assay 004104, Diez-Roux et al. (2011)) . At later stages of embryonic development Fbx2 remains highly specific to the inner ear and is enriched in the auditory and vestibular sensory epithelia cells including sensory hair cells and supporting cells ( Fig. 1B-B `, and Hartman et al. (2015) ). These data suggested that at both the transcript and protein level Fbxo2 stands out as a highly specific and robust marker of the otic sensory lineage, which motivated us to focus on this gene.
Fbx2 (also called Fbs1, NFB42, and OCP1) is a sugar chain specific F-box protein that was previously identified in the adult guinea pig organ of Corti where it was hypothesized to form a complex with Skp1 and interact with connexin 26 (Cx26), an essential cochlear gap junction protein (Henzl et al., 2001; Henzl et al., 2004; Thalmann et al., 2003; Thalmann et al., 1997) . Fbx2 binds to high-mannose, asparagine-linked glycoproteins that are associated with the endoplasmic reticulum, and is believed to facilitate their degradation through the ubiquitin proteasome pathway (Yoshida et al., 2002; Yoshida et al., 2003) . Fbxo2 -/mice have normal inner ear morphology and hearing prior to two months of age; thereafter, they exhibit age-related cochlear degeneration and hearing loss (Nelson et al., 2007) . This suggests that in the adult inner ear Fbx2 plays an essential role, presumably in protein quality control.
It is interesting that Fbxo2 is expressed robustly from early otic development, but the knockout does not display a detectable phenotype until months later. Fbxo2 is also expressed in the adult brain where there is evidence it may influence NMDA subunit distribution as well as attenuate Alzheimer's disease amyloidosis by mediating ubiquitination of beta-secretase (Atkin et al., 2014; Atkin et al., 2015; Erhardt et al., 1998; Gong et al., 2010) . It is currently not known when Fbxo2 becomes expressed in the brain or which populations of neurons most highly express this gene. The lack of substantial expression signal for Fbxo2 in other embryonic tissues indicates that levels in other tissues are much lower than in the inner ear, or that expression is initiated at later embryonic or postnatal stages in other tissues.
We sought to exploit the otic-specific expression of Fbxo2 by generating embryonic stem cells and a mouse line in which Fbxo2-expressing cells can be identified, isolated, and genetically manipulated for studies of inner ear development and function. Such a reporter system could serve as a tool to solve the issue of cell heterogeneity in stem cell-based model systems of inner ear development, including somatic direct programming and directed stem cell differentiation approaches, which are currently reliant on relatively non-specific markers and tools for identifying and accessing newly generated inner ear cell types. To achieve these goals, we generated a tricistronic reporter cassette (VHC) consisting of the bright fluorescent nuclear protein H2B-Venus (V), a hygromycin resistance gene (HygroR = H), and the CreERt2 gene (C) that was knocked into the Fbxo2 locus. Fbxo2 VHC/WT ES cells displayed specific and early otic progenitor cell expression of the Venus reporter that persisted when the otic progenitors differentiated into supporting cells and hair cell-like cells. In Fbxo2 VHC/WT mice, H2B-Venus expression is moderate in the early otic vesicle and becomes strong and concentrated throughout the floor of the developing cochlear duct and later in supporting cells and hair cells of the organ of Corti. In neonatal and adult mice, H2B-Venus expression is also detectable in subsets of other cochlear cell types.
Outside the inner ear, we identified strong reporter gene expression in adult cerebellar granule cells.
We further validated the reporter system's selection marker for hygromycin as well as the use of tamoxifen-induced and CreERt2-mediated recombination. In summary, the Fbxo2 VHC reporter system presented here exploits the embryonic specificity of Fbxo2 expression to enable specific delineation and manipulation of otic (pro-) sensory cells in culture systems and mice.
RESULTS

Generation of multicistronic reporter cassettes and Fbxo2 VHC knock-in ES cells
We developed a multifunctional reporter system for 1) expression of a bright fluorescent protein for imaging, 2) conferring drug-resistance for selection, and 3) enabling inducible Cre-mediated recombination for lineage tracing and conditional mutagenesis when combined with LoxP mouse models. Viral 2A peptides are small "self-cleaving" amino acid chains that enable expression of multiple proteins from a single transcript by mediating a ribosomal skipping of the last peptide bond at the C-terminus (Szymczak and Vignali, 2005) . We designed and constructed a tricistronic reporter cassette using the P2A peptide, from porcine teschovirus-1, which has been shown to have high cleavage efficiency in human cell lines, mice, and zebrafish (Kim et al., 2011) . The resulting H2B-Venus-P2A-HygroR-P2A-CreER cassette (abbreviated VHC) encodes expression of three products from a single transcript (Fig. S1A ). The first product, H2B-Venus, is a carboxyl-terminal fusion of human histone H2B with the yellow fluorescent Venus protein. Nuclear located H2B fluorescent fusion proteins have been widely used for studies of cell cycle, apoptosis, and chromatin dynamics (Fraser et al., 2005; Kang et al., 2013; Nowotschin et al., 2009 ). The second cDNA, HygroR encodes hygromycin phosphotransferase that confers resistance to hygromycin B for selection of cells in culture (Blochlinger and Diggelmann, 1984; Giordano and McAllister, 1990) . HygroR has been used effectively in 2Amediated bicistronic expression for selection of ES cells following dual recombinase mediated cassette exchange (Osterwalder et al., 2010) . The third cDNA in the VHC cassette is CreERt2, which enables inducible Cre-LoxP recombination for lineage tracing (Feil et al., 1997; Matsuda and Cepko, 2007) .
The sequence of the three proteins in the VHC cassette was designed to minimize possible issues associated with the 2A "tag" that remains on the carboxyl terminus of any protein upstream of the 2A peptide (Szymczak and Vignali, 2005) . We therefore placed CreERt2 in the last position to ensure that the estrogen receptor fusion remains unmodified. A similar strategy has been used successfully in knock-in mice for multicistronic 2A-peptide cassettes expressing CreERt2 downstream of other proteins (Imuta et al., 2013) . The VHC cassette was designed with two P2A peptides of identical amino acid sequence with slightly different cDNA sequences to reduce repetitive sequences ( Fig. S1A ). Upstream of the VHC translation initiation codon, we included a Kozak consensus sequence (GCCACCATG (Kozak, 1987) ) overlaid with an in-frame eight-nucleotide rare restriction endonuclease recognition site (Fse-1, GGCCGGCC (Nelson et al., 1990) ) to enable scarless assembly of promoter sequences or homology arms to the 5`-end of the reporter cassette ( Fig. S1A ).
We tested the VHC cassette in cell culture to verify functional performance of the three reporter proteins (Fig. S1 B-G) . The VHC cassette was cloned downstream of the ubiquitous cytomegalovirus immediate early enhancer-chicken beta-actin hybrid (CAG) promoter ( Fig. S1B ) (Okabe et al., 1997; Sakai et al., 1995) . Embryonic fibroblasts generated from Ai14 Cre reporter mice (Madisen et al., 2010) were transfected with pCAG-VHC, treated with 4-hydroxytamoxifen (4OHT) and HygroB, and then assayed for expression of Venus. Yellow fluorescence from Venus expression was bright and localized to the nucleus and Venus-positive cells treated with 4OHT expressed the tdTomato Cre reporter ( Fig S1D-F ). HygroB treatment resulted in a substantial increase in the fraction of Venusexpressing cells ( Fig. S1G ). To generate the targeting construct to knock-in the VHC cassette to the Fbxo2 locus, we cloned the VHC cassette into the PGKneolox2DTA.2 plasmid ( Fig. S1H ) (Hoch and Soriano, 2006 ) that contains a neomycin selection cassette flanked by LoxP sites (to allow subsequent removal by Cre recombination) and a PGKdtabpA (for negative selection of non-homologous insertion).
We then generated knock-in Fbxo2 VHC ES cells by cloning homology arms flanking the start site of the Fbxo2 gene into the VHC targeting vector and performed homologous recombination and selection of neomycin-resistant ES cell colonies (Fig. 1C ).
We built and validated three additional multicistronic cassettes as part of a toolbox of plasmids to facilitate use of this approach in a variety of systems and (Fig. S2 ). We generated four versions of the cassette with alternative fluorescent proteins, specifically H2B-Venus (VHC), H2B-Emerald (EHC), H2B-tdTomato (tdTHC), and H2B-Teal/mTFP1 (mTHC) (Fig. S2A ). These four fluorescent proteins are spectrally distinct and among the brightest in their respective classes (Day and Davidson, 2009 ). The properties of these fluorescent proteins are well characterized and they can be excited by common laser lines and distinguished by their excitation and emission spectra ( Fig S2B-C) . Three plasmids were generated for each of the multicistronic cassettes: a promoter-less expression plasmid, a CAG promoter plasmid for constitutive expression, and a PGKneolox2DTA.2 plasmid for generation of targeting vectors by addition of homology arms ( Fig. S2H ).
Venus marks Fbxo2 VHC ES cell-derived inner ear sensory epithelia cells
Here we show proof-of-principle that the Fbxo2 VHC reporter is useful in specifically delineating otic cells produced from ES cells by directed differentiation. Fbxo2 VHC/WT ES cell aggregates were sequentially treated with small molecules and recombinant proteins to manipulate Bmp, TGFβ, Fgf, and Wnt signaling pathways, according to a previously established three-dimensional culture system for otic sensory differentiation (DeJonge et al., 2016; Koehler and Hashino, 2014) . This protocol promotes stepwise induction of non-neural and preplacodal ectoderm, followed by development of otic vesiclelike structures by day 12-14, which ultimately contain mechanosensory hair cells and supporting cells by day 16 or later (Koehler and Hashino, 2014) . In Fbxo2 VHC/WT ES cell-derived aggregates at day 12 of the otic differentiation protocol, epithelial cysts co-express Venus and Pax2 ( Fig. 2A-A` ). Pax2 is expressed in the early otic placode and synergizes with Pax8 for specification of inner ear (Bouchard et al., 2010; Burton et al., 2004; Hans et al., 2004; Nornes et al., 1990) . During early otic morphogenesis at E10.5 in the mouse embryo Pax2 and Fbx2 are coexpressed in the otic vesicle (Hartman et al., 2015) . We observed Fbxo2 VHC/WT aggregates at 17 days in vitro containing numerous epithelial cysts 
Venus expression in the developing and adult cochlea of Fbxo2 VHC mice
Two different Fbxo2 VHC/WT ES cell clones were used to generate two independent Fbxo2 VHC/WT knock-in mouse lines that showed identical expression patterns. All data reported here is derived from one of the two lines. Founder Fbxo2 VHC/WT mice were crossed to a ubiquitous zygotic Cre driver mouse line (Eiia-Cre, Lakso et al. (1996) ) to remove the pgk-Neo cassette required for positive selection of ES cell clones (Fig. 1C ). We examined Venus expression in developing and adult Fbxo2 VHC/WT mice and found that expression overlaps with Fbx2 immunoreactivity while also revealing more subtle expression level differences between cell types. Venus expression is moderate in the otic vesicle, where it overlaps with Fbx2 protein and the neurosensory domain marker Jag1 ( Fig. 4A-A` ). During cochlear morphogenesis, Venus expression is particularly intense throughout the floor of the developing cochlear duct, within the expression domain of Gata3 ( Fig. 4B-B` ), which is involved in specification of the prosensory domain (Luo et al., 2013) . In the apex of the cochlea at E13.5, Venus expression spans the width of the cochlear floor and overlaps with the prosensory marker Sox2 ( Fig. 4C -C`). A gradient was notable from the apex to the base where Venus expression was markedly lower on the medial side of the cochlea including the prosensory region and the greater epithelial ridge ( Fig 4B-C`) . Throughout embryonic and postnatal cochlear development this gradient of Venus and Fbx2 expression in the medial portion of the cochlea is maintained, so that the domain of Venus expression is wider in the apex and narrower and more restricted to the lateral cells in the base. This is markedly obvious in sections from E16.5 cochlea stained with antibodies to mark the organ of Corti and prosensory domain ( 
Tamoxifen-inducible Cre-recombination in the cochlea of Fbxo2 VHC mice
We tested Cre recombination in Fbxo2 VHC mice by crossing to the Ai14 Cre-reporter mouse (Madisen et al., 2010) . Tamoxifen was administered as a single dose at various time points and samples were analyzed after 3 or more days for tdTomato-expressing cells. Cre recombination occurs sparsely in the cochlea when induced in mid-gestation embryos with a single dose of tamoxifen to the pregnant dam ( Fig. 6A-C` ). The frequency of tdTomato-expressing cells increases progressively at later stages of embryogenesis and with age in postnatal to adult animals ( Fig. 6D-K) . Tracing in the neonatal cochlea occurs sporadically in organ of Corti supporting cells and hair cells and more frequently in lateral epithelial ridge supporting cells ( Fig 6E-H` ). An increasing base to apex gradient of recombination frequency in the neonatal organ of Corti correlates with lower Venus expression levels in the base ( 
Cochlear degeneration in aged homozygous Fbxo2 VHC/VHC mice
The modified Fbxo2 VHC locus introduces a TGA stop codon after the VHC cassette and therefore is expected to be a null allele for Fbx2 (Fig. 1C ). We found that homozygous Fbxo2 VHC/VHC mice exhibit age-related cochlear degeneration, which aligns with previous observations in Fbx2-null mice (Nelson et al., 2006) . We compared cochleae of Fbxo2 VHC/WT and Fbxo2 VHC/VHC littermates (FVB/NJ background) at eight months of age and performed immunohistochemistry for Myosin7a and Sox2 to label hair cells and adjacent supporting cells, respectively (Fig. S3 ). Cochleae of heterozygous animals in these aged animals were indistinguishable from P30 samples and did not display any loss of cells or abnormal cell morphologies ( Fig. S3A-B 
Fbxo2 VHC reporter activity marks a subset of vestibular hair cells
In the utricle, Venus is initially detected at low levels in some Sox2-labeled progenitors/supporting cells (E13.5, Fig. S4A ). At E16.5, some hair cells express Venus at higher levels, while expression in the supporting cell layer remains low ( Fig. S4B-D) . In postnatal and adult vestibular organs, Venus is bright in nuclei of cells located almost exclusively in the peripheral/extrastriolar zones (Fig. 7) . In the mammalian macular organs, the utricle and saccule, the striolar region of sensory epithelium is immediately adjacent to the line of hair cell polarity reversal and displays unique features including oncomodulin (Ocm)-positive hair cells and afferent dendrites exhibiting primarily calyx-only morphology and calretinin expression (Desai et al., 2005b; Hoffman et al., 2018; Simmons et al., 2010) . The saddle-shaped semi-circular canal cristae exhibit a central zone with features very similar to the macular striola (Desai et al., 2005a) . Close examination and immunohistochemical analysis of Fbxo2 VHC/WT macular organs show that the Venus-expressing cells are Myosin6-positive hair cells located outside of the striolar zone ( Fig. 7A-B`` ). Fbx2 immunoreactivity is present in Venus-positive cells and appears to be enriched in perinuclear cytoplasm (Fig. 7C ).
Mammalian vestibular organs have two major types of hair cells, types I and II, present in similar numbers (for review see Eatock and Songer (2011) ). Type I vestibular hair cells are characterized by calyx afferent innervation while type II hair cells are innervated by bouton nerve endings (Goldberg et al., 1992; Lysakowski and Goldberg, 1997) . In mature vestibular organs, calretinin is expressed in type II hair cells but not type I hair cells (Dechesne et al., 1994; Li et al., 2008) . Vestibular sensory epithelia costained with calretinin and the neuronal marker Tuj1 showed that Venus-positive cells are calretininnegative and are associated with calretinin-negative calyxes in the extrastriolar region, suggesting that Venus expression is specific to extrastriolar type I hair cells (Fig. 7D ). To further validate this finding, we immunolabeled for tenascin, an extracellular protein specifically found in the region between type I vestibular hair cells and their surrounding afferent nerve calyxes (Lysakowski et al., 2011; Warchol and Speck, 2007) . We found that each Venus-positive cell is surrounded by a crescent of tenascin immunoreactivity ( Fig. 7E-E``) . The Fbxo2 VHC reporter shows a similar pattern of expression in semicircular canal cristae to that observed in macular organs. Venus is expressed in hair cell nuclei in the peripheral zones but is absent from the central zone (Fig. 7F) . As in the utricle, Venus expression is juxtaposed with the striolar hair cell marker oncomodulin (Fig. 7F`) . Moreover, Venus-labeled nuclei are nearly always associated with rings or crescents of tenascin immunoreactivity in the crista (Fig. 7G-G` ).
We conclude that Fbxo2 VHC specifically labels populations of type I hair cells found in the extrastriolar zones of the maculae and the peripheral zones of the cristae.
Cre recombination in Fbxo2 VHC vestibular organs is robust and consistent with the Venus expression observed in developing and adult organs (Fig. S5) . When tamoxifen was delivered to pregnant dams at E13.5 no Cre recombination was observed in the vestibular organs (data not shown). An E15.5 dose of tamoxifen resulted in occasional recombination in hair cells in the peripheral/extrastriolar zones when samples were collected at E18.5 ( Fig. S5A-A`) . Moreover, labeled cells, which were presumably We examined vestibular organs of homozygous Fbxo2 VHC/VHC mice at eight months of age to determine if there are any signs of degeneration in the vestibule, given the progressive cochlear degeneration phenotype observed in aged Fbx2-null mice. No indication of gross morphological abnormalities or cell loss was observed in vestibular organs of homozygous animals (Fig. S6 ). Distribution of Venus-positive cells and calyxeal nerve endings also appeared normal in the utricle and crista. Neither did we observe any circling or whirling behavior in Fbxo2 VHC/VHC animals, consistent with previously reported analysis of Fbx2-null animals (Nelson et al., 2006) .
Cerebellar granule cells express the Fbxo2 VHC reporter
We examined organism-wide Venus expression and Cre reporter activity in whole embryos and vibratome sections from E10.5 to birth to identify other sites of substantial Fbxo2 VHC expression besides the inner ear. This analysis identified cerebellar granule cells and their precursors as the only other population exhibiting expression of the reporter at levels comparable to the inner ear. In sagittal vibratome sections of the head at E16.5, bright Venus expression is present in the external granular layer of the cerebellum (Fig. S7A-C) . The external granular layer, or external germinal zone, is a temporary population of proliferating progenitors located at the subpial surface of the cerebellum (for review see (Marzban et al., 2014) ). This population is Atoh1-dependent and is derived from the rhombic lip at the dorsal edge of the fourth ventricle between E12.5 and E17 (Machold and Fishell, 2005; Wang and Zoghbi, 2001) . In lineage tracing experiments, injection of tamoxifen at E13.5 resulted in moderate Cre recombination within this population, and no other sites of the brain (Fig. S8A-A`` ).
The vast majority of cells from the external granular layer produce cerebellar granule cells during the postnatal period in rodents. During rodent postnatal development, granule cells differentiate and migrate rostrally across the Purkinkje cell layer to form the granular layer, the innermost layer of the mature cerebellum. Tamoxifen administration at P1 resulted in labeled cells in the external granular layer and in cells that appear to be migrating to the inner granular layer ( Fig. S8B-B`` ). In adults, Venus fluorescence is bright in the granular layer in all lobes of the cerebellum (Fig. S7D-D` ). There are also some other regions of the adult brain that harbor Venus expressing cells, including the pons, medulla and hippocampus, but the intensity of fluorescence is lower and expression is sparse in these areas ( Fig. S7D-D` ). Closer examination of the cerebellum revealed bright Venus expression in densely packed nuclei of the granular layer, which is bordered by the Purkinje layer, labeled with calbindin ( Fig.   S7E -E`). Venus-expressing cells are positive for calretinin ( Fig. S7F-F`) , which labels cerebellar granule cells in adult rodents (Resibois and Rogers, 1992) . Cerebellar tissue from eight-month old Fbxo2 VHC/WT and littermate Fbxo2 VHC/VHC mice were stained with antibodies to calbindin and calretinin to visualize the Purkinje cells and granule cells, respectively ( Fig. S7G-H) , and no abnormalities were observed.
DISCUSSION
Genetically engineered mouse models including gene targeted and transgenic reporters are essential tools of discovery in mammalian developmental biology (Bouabe and Okkenhaug, 2013) . Specificity and utility of a transgenic model depends on two main factors. First, a tissue or cell-specific promoter/ locus is needed to express genes either consistently or transiently in the organ or cell lineage of interest. The second factor is the transgene product that is expressed under control of the tissue or cell-specific promoter; this might be a reporter protein or a more complex construct. The number of various promoter and reporter combinations is ultimately dependent on the research area, but usually restrictive so that it is often necessary to cleverly combine existing mouse models to address specific biological questions. Here, we introduce a combination of a highly specific otic lineage locus with a multicistronic reporter/effector cassette that enables a wide variety of functional experiments. We provide a toolbox of different reporter multicistronic cassettes that all have been tested, which are freely available to be combined with any gene provided by the user.
Moreover, we have thoroughly characterized the otic lineage-specific showed higher rates of Cre recombination as well as higher levels of Fbx2 immunoreactivity. Fbx2 and the Fbxo2 VHC reporter both show a steady increase in expression levels during later development and maturation, so the highest levels of expression are found in mature cells. The locations of highest expression in the adult include the organ of Corti and the granular layer of the cerebellum. In the late embryonic and neonatal cochlea, the Fbxo2 VHC reporter revealed a gradient with highest expression in the lateral supporting cells. In vestibular organs, expression of the Fbxo2 VHC reporter is highest in a unique subset of type I hair cells, some of which appear to be specified during embryonic development as indicated by lineage tracing and retained Venus expression. Overall expression patterns of the Fbxo2 VHC reporter are consistent with Fbx2 protein expression levels reported here as well as in previous work (Atkin et al., 2014; Hartman et al., 2015; Nelson et al., 2007) . As well, observed In the organoid system we show that 1) the Fbxo2 VHC reporter is effective for delineating the otic lineage, 2) Venus expression is found in both hair cells and supporting cells at moderate to high levels, and 3) elevated Venus expression can be found in some patches of hair cells and supporting cells.
Interestingly, this pattern is distinct from that of the native vestibular organs in Fbxo2 VHC mice, in which expression in supporting cells is quite low and only a subset of hair cells express moderate to high Venus. This was somewhat unexpected given that inner ear organoids produced from other ES cell lines with the same protocol have been shown to contain hair cells that are morphologically and functionally similar to native vestibular hair cells (Liu et al., 2016) . In Fbxo2 VHC organ of Corti, expression of Venus is found in all epithelial cells, and is elevated in the supporting cells of the lateral domain during embryonic and postnatal development. Expression of Venus in what appears to be all supporting cells and hair cells in organoids, indicates that regulation of Fbxo2 in these ES cell-derived sensory epithelia may not be entirely recapitulating the signaling of vestibular organogenesis. The presence of patches of higher expressing cells within organoids suggests that Fbxo2 may be affected by signaling domains that may occur in the aggregate cultures. Signaling from BMP, Wnt, and Notch regulate mediolateral patterning of the cochlea and likely affect the gradient of Fbx2/Fbxo2 VHC in the organ of Corti (Munnamalai and Fekete, 2016; Ohyama et al., 2010) . Further investigation into the properties of otic organoid cells and signaling can be facilitated by use of the Fbxo2 VHC reporter. As well, Fbxo2 VHC ES cells may be applied to ES cell models of cerebellar development (Salero and Hatten, 2007; Srivastava et al., 2013) .
In conclusion, the Fbxo2 VHC reporter system is a versatile tool for the study of developmental biology of the inner ear and the cerebellum. These validated mouse and ES cell models complement each other and can be used in parallel to take advantage of the relative strengths of each system. The multicistronic reporter approach and spectrally distinct reporter toolbox developed here is now available as a resource for the developmental biology community.
MATERIALS AND METHODS
Cloning
Multicistronic cassettes were constructed using enzymatic assembly of overlapping DNA fragments (Gibson assembly, (Gibson, 2011) ). Source plasmids for cloning are listed in supplemental methods.
To generate the Fbxo2-VHCpgkNeoDTA targeting construct (Figure 1 C) , homology arms flanking Exon 1 of Fbxo2 were amplified from E14tg2a ES cell genomic DNA using high fidelity PCR. Further details are provided in supplemental methods.
Generation of Fbxo2 VHC mouse ES cells and mice
ES cell manipulation and selection was performed by the Stanford Transgenic, Knockout and Tumor Model Center (TKTMC). Further details are provided in supplemental methods.
Fbxo2 VHC mouse ES cell culture and generation of otic organoids
Fbxo2 VHC/WT ES cells were expanded from the same clone used to produce the mouse line described in this report. ES cells were cultured without feeders in "2iLif" conditions (leukemia inhibitory factor (LIF) in serum-free N2B27 supplemented with MEK inhibitor PD0325901 (1 μM) and GSK3 inhibitor CHIR99021 (3 μM) (Ying et al., 2008) ). Inner ear sensory epithelia were differentiated from Fbxo2 VHC/ WT ES cells in serum-free 3D aggregate culture as previously described with only very minor modifications (Koehler and Hashino, 2014; Koehler et al., 2013) . Briefly, Fbxo2 VHC/WT ES cells in 2iLif were washed well in DMEM/F12 then dissociated with Accutase (Stem Cell Technologies) and diluted to a concentration of 30,000 cells per ml in ectodermal differentiation medium and aliquoted at 100µl per well in 96-well ultra low attachment plates to form aggregates. Matrigel was added 24 hours later on day 1, BMP-4 and SB-431542 were added on day 3, and FGF-2 and LDN-193189 (FGF/LDN) were added on day 4 to 5. On day 8, aggregates were transferred to long-term culture to be maintained until endpoint analysis. As described by Koehler and Hashino (2014) , the timing of FGF/LDN was an important factor in optimizing the protocol; application on day 4.0 to 4.25 produced higher rates of organoids than did application on 4.5 to 5.0 in Fbxo2 VHC/WT ES cells.
Fluorescent immunohistochemistry and imaging
Organoids, whole embryos, or dissected tissues were processed either whole or in vibratome sections.
Samples were permeabilized with 2% Triton X-100 in PBS for one hour at room temperature then incubated in blocking solution (10% fetal bovine serum, 0.5% Triton X-100, in PBS) overnight at 4°C. Primary antibodies (see Supplemental Methods for list of antibodies) were diluted in blocking solution and samples were incubated for two to three nights at 4°C with rocking. Samples were washed then incubated in species-specific Alexafluor 488-/568-/ or 647-conjugated secondary antibodies (Life Technologies) diluted in blocking solution. Vibratome sections were incubated for at least one hour in 50% glycerol in PBS then mounted in the same on a glass concavity slide and coverslipped for imaging. Aggregates and whole mount tissue specimens were optically cleared by incubating at 4°C with rocking in Scale/A2 (Hama et al., 2011) for at least 5 days, with three changes of the Scale/A2 solution. Cleared samples were mounted in Scale/A2 between glass coverslips in imaging chambers consisting of 2-3 stacked 0.5 mm adhesive silicone spacers, modified from SecureSeal Hybridization Chambers (Grace Biolabs). Confocal fluorescent imaging was performed with upright Zeiss LSM700 or LSM880 confocal microscopes running Zen software and using 10X, 20X, or 40X objectives. ImageJ/ FIJI was used for image analysis and export of z-stack data to video (AVI). Adobe CS6 (Adobe Systems) was used for processing images into figures. Keynote (Apple) was used to combine video files and generate movies with titles and annotations. Further details are provided in Supplemental Methods.
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